New chemical entities with poor aqueous solubility require the use of technologies to enable sufficient oral bioavailability of these NCEs following administration.
William Porter III
Advertisement
William Porter III, is senior chemist, R&D, at Dow Pharma & Food Solutions.
Articles by William Porter III
Advertisement
Latest Updated Articles
Polymers for Solubility EnhancementPublished: August 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
